Your session is about to expire
← Back to Search
High-Intensity Interval Training for Non-alcoholic Fatty Liver Disease (AMPED Trial)
AMPED Trial Summary
This trial found that a single session of high-intensity interval training (HIIT) improved liver fat and insulin sensitivity in those with NAFLD.
AMPED Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAMPED Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AMPED Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 69 years old.My diabetes is not well-controlled.I have fatty liver disease not caused by alcohol.My liver has mild to moderate scarring.I cannot walk more than 2 blocks without stopping.I have a liver condition.My BMI is over 30.I am currently experiencing heart problems.My liver condition is confirmed by specific tests to be severe.My cancer is currently active.I am between 18 and 69 years old.My liver biopsy shows I have NASH with a NAS score over 4, MRI-PDFF over 5%, and fibrosis stage 1-3.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Standard of Care
- Group 2: Exercise Arm 2
- Group 3: Exercise Arm 1
Frequently Asked Questions
Is this research endeavor still enrolling participants?
"The trial, which was first listed on August 30th 2022 and recently modified on November 14th 2022, is calling for participants according to data hosted by clinicaltrials.gov."
Who would be an appropriate candidate for participation in this clinical experiment?
"The eligibility criteria for this research endeavour stipulates that patients should have Non-Alcoholic Fatty Liver Disease and be between 18 to 69 years of age. Approximately 45 individuals will be selected as participants in the study."
Is this research project accepting participants over the age of 40?
"This clinical trial is open to adult patients, aged 18 - 69."
What is the cumulative enrollment of this experiment?
"Affirmative. Clinicaltrials.gov indicates that this clinical trial is currently in recruitment mode, as it was initially posted on August 30th 2022 and last amended on November 14th 2022. There are 45 participants needed from 1 medical facility."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger